Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05582304 · ClinicalTrials.gov registry record · NA
Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05582304 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 40 participants, below the 138-participant average among 20 other Visual Acuity trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05582304, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a split-plot design, randomized, parallel, double-masked feasibility study to evaluate the role of a test lens on contrast sensitivity with and without glare.
Conditions Studied
Interventions
- DEVICE Test Lens
- DEVICE Control Lens
Study Locations (1)
Georgia
- University of Georgia - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-10-31 |
| Est. Completion | 2022-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05582304
The ClinicalTrials.gov registry entry for NCT05582304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 20 other Visual Acuity trials with a reported enrollment target (71% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which Test Lens is the first listed.
NCT05582304 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05582304 about?
NCT05582304 is a clinical study titled "Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study". This will be a split-plot design, randomized, parallel, double-masked feasibility study to evaluate the role of a test lens on contrast sensitivity with and without glare.
What is the current status of trial NCT05582304?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-10-31. Estimated completion is 2022-12-08.
What conditions does trial NCT05582304 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT05582304?
The interventions under investigation include: Test Lens (DEVICE), Control Lens (DEVICE).
Who is sponsoring clinical trial NCT05582304?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05582304 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.